Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_assertion type Assertion NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_head.
- NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_assertion description "[A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_provenance.
- NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_assertion evidence source_evidence_curated NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_provenance.
- NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_assertion SIO_000772 12970779 NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_provenance.
- NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_assertion wasDerivedFrom ctd_human-20130708 NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_provenance.
- NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_assertion wasGeneratedBy ECO_0000218 NP9629.RASUrAqyVDEX4nPHLpX7eAaBLVJzjgx82rPEvf-XzzyPY130_provenance.